過敏性腸症候群（IBS）のグローバル市場2021

• 英文タイトル：Global Irritable Bowel Syndrome (IBS) Sales Market Report 2021

• レポートコード：QAF27753
• 出版社/出版日：QYResearch / 2021年4月6日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、134ページ
• 納品方法：Eメール（即日納品）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥592,000 (USD4,000)	▷ お問い合わせ
Multi User	￥888,000 (USD6,000)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本市場調査資料では、世界の過敏性腸症候群（IBS）市場について種類別（IBS-D薬、IBS-C薬、その他）、用途別（女性、男性）、地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2016年～2027年までの市場規模と予測（販売量、売上、価格）、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・過敏性腸症候群（IBS）市場の概要
・世界の主要地域別過敏性腸症候群（IBS）市場規模2016-2027
・主要プレイヤーの競争状況・市場シェア
・世界の過敏性腸症候群（IBS）市場規模2016-2021：種類別（IBS-D薬、IBS-C薬、その他）
・世界の過敏性腸症候群（IBS）市場予測2012-2027：種類別（IBS-D薬、IBS-C薬、その他）
・世界の過敏性腸症候群（IBS）市場規模2016-2021：用途別（女性、男性）
・世界の過敏性腸症候群（IBS）市場予測2012-2027：用途別（女性、男性）
・過敏性腸症候群（IBS）のアメリカ市場規模と予測2016-2021
・過敏性腸症候群（IBS）のヨーロッパ市場規模と予測2016-2021
・過敏性腸症候群（IBS）の中国市場規模と予測2016-2021
・過敏性腸症候群（IBS）の日本市場規模と予測2016-2021
・過敏性腸症候群（IBS）の東南アジア市場規模と予測2016-2021
・過敏性腸症候群（IBS）のインド市場規模と予測2016-2021
・主要プレイヤーの企業情報：事業概要・売上・企業動向
（Bausch Health、Allergan、Takeda、Sucampo Pharmaceuticals (Mallinckrodt)、Sebela Pharmaceuticals Inc、Astellas Pharmaceuticals）
・過敏性腸症候群（IBS）の製造コスト分析
・販売チャネル、流通業者、顧客
・過敏性腸症候群（IBS）の市場動向・機会・課題
・調査の結論

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.

Market Analysis and Insights: Global Irritable Bowel Syndrome (IBS) Market
The global Irritable Bowel Syndrome (IBS) market was valued at US$ 3591.2 in 2020 and will reach US$ 5573.4 million by the end of 2027, growing at a CAGR of 7.6% during 2022-2027.

Global Irritable Bowel Syndrome (IBS) Scope and Market Size
The global Irritable Bowel Syndrome (IBS) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Irritable Bowel Syndrome (IBS) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
IBS-D Drug
IBS-C Drug
Other

Segment by Application
Women
Men

The Irritable Bowel Syndrome (IBS) market is analysed and market size information is provided by regions (countries). Segment by Application, the Irritable Bowel Syndrome (IBS) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Bausch Health
Allergan
Takeda
Sucampo Pharmaceuticals (Mallinckrodt)
Sebela Pharmaceuticals Inc
Astellas Pharmaceuticals

レポート目次

1 Irritable Bowel Syndrome (IBS) Market Overview
1.1 Irritable Bowel Syndrome (IBS) Product Scope
1.2 Irritable Bowel Syndrome (IBS) Segment by Type
1.2.1 Global Irritable Bowel Syndrome (IBS) Sales by Type (2016 & 2021 & 2027)
1.2.2 IBS-D Drug
1.2.3 IBS-C Drug
1.2.4 Other
1.3 Irritable Bowel Syndrome (IBS) Segment by Application
1.3.1 Global Irritable Bowel Syndrome (IBS) Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Women
1.3.3 Men
1.4 Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts (2016-2027)
1.4.1 Global Irritable Bowel Syndrome (IBS) Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Irritable Bowel Syndrome (IBS) Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Irritable Bowel Syndrome (IBS) Price Trends (2016-2027)

2 Irritable Bowel Syndrome (IBS) Estimates and Forecasts by Region
2.1 Global Irritable Bowel Syndrome (IBS) Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Irritable Bowel Syndrome (IBS) Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2021)
2.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region (2016-2021)
2.3 Global Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Irritable Bowel Syndrome (IBS) Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Irritable Bowel Syndrome (IBS) Estimates and Projections (2016-2027)
2.4.2 Europe Irritable Bowel Syndrome (IBS) Estimates and Projections (2016-2027)
2.4.3 China Irritable Bowel Syndrome (IBS) Estimates and Projections (2016-2027)
2.4.4 Japan Irritable Bowel Syndrome (IBS) Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Irritable Bowel Syndrome (IBS) Estimates and Projections (2016-2027)
2.4.6 India Irritable Bowel Syndrome (IBS) Estimates and Projections (2016-2027)
3 Global Irritable Bowel Syndrome (IBS) Competition Landscape by Players
3.1 Global Top Irritable Bowel Syndrome (IBS) Players by Sales (2016-2021)
3.2 Global Top Irritable Bowel Syndrome (IBS) Players by Revenue (2016-2021)
3.3 Global Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020)
3.4 Global Irritable Bowel Syndrome (IBS) Average Price by Company (2016-2021)
3.5 Manufacturers Irritable Bowel Syndrome (IBS) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Irritable Bowel Syndrome (IBS) Market Size by Type
4.1 Global Irritable Bowel Syndrome (IBS) Historic Market Review by Type (2016-2021)
4.1.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Type (2016-2021)
4.1.3 Global Irritable Bowel Syndrome (IBS) Price by Type (2016-2021)
4.2 Global Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2022-2027)
4.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Type (2022-2027)
4.2.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Type (2022-2027)
5 Global Irritable Bowel Syndrome (IBS) Market Size by Application
5.1 Global Irritable Bowel Syndrome (IBS) Historic Market Review by Application (2016-2021)
5.1.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
5.1.2 Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Application (2016-2021)
5.1.3 Global Irritable Bowel Syndrome (IBS) Price by Application (2016-2021)
5.2 Global Irritable Bowel Syndrome (IBS) Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2022-2027)
5.2.2 Global Irritable Bowel Syndrome (IBS) Revenue Forecast by Application (2022-2027)
5.2.3 Global Irritable Bowel Syndrome (IBS) Price Forecast by Application (2022-2027)

6 North America Irritable Bowel Syndrome (IBS) Market Facts & Figures
6.1 North America Irritable Bowel Syndrome (IBS) Sales by Company
6.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Company (2016-2021)
6.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021)
6.2 North America Irritable Bowel Syndrome (IBS) Sales Breakdown by Type
6.2.1 North America Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2016-2021)
6.2.2 North America Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2022-2027)
6.3 North America Irritable Bowel Syndrome (IBS) Sales Breakdown by Application
6.3.1 North America Irritable Bowel Syndrome (IBS) Sales Breakdown by Application (2016-2021)
6.3.2 North America Irritable Bowel Syndrome (IBS) Sales Breakdown by Application (2022-2027)

7 Europe Irritable Bowel Syndrome (IBS) Market Facts & Figures
7.1 Europe Irritable Bowel Syndrome (IBS) Sales by Company
7.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Company (2016-2021)
7.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021)
7.2 Europe Irritable Bowel Syndrome (IBS) Sales Breakdown by Type
7.2.1 Europe Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2016-2021)
7.2.2 Europe Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2022-2027)
7.3 Europe Irritable Bowel Syndrome (IBS) Sales Breakdown by Application
7.3.1 Europe 134 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 134 Sales Breakdown by Application (2022-2027)

8 China Irritable Bowel Syndrome (IBS) Market Facts & Figures
8.1 China Irritable Bowel Syndrome (IBS) Sales by Company
8.1.1 China Irritable Bowel Syndrome (IBS) Sales by Company (2016-2021)
8.1.2 China Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021)
8.2 China Irritable Bowel Syndrome (IBS) Sales Breakdown by Type
8.2.1 China Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2016-2021)
8.2.2 China Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2022-2027)
8.3 China Irritable Bowel Syndrome (IBS) Sales Breakdown by Application
8.3.1 China 245 Sales Breakdown by Application (2016-2021)
8.3.2 China 245 Sales Breakdown by Application (2022-2027)

9 Japan Irritable Bowel Syndrome (IBS) Market Facts & Figures
9.1 Japan Irritable Bowel Syndrome (IBS) Sales by Company
9.1.1 Japan Irritable Bowel Syndrome (IBS) Sales by Company (2016-2021)
9.1.2 Japan Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021)
9.2 Japan Irritable Bowel Syndrome (IBS) Sales Breakdown by Type
9.2.1 Japan Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2016-2021)
9.2.2 Japan Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2022-2027)
9.3 Japan Irritable Bowel Syndrome (IBS) Sales Breakdown by Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Irritable Bowel Syndrome (IBS) Market Facts & Figures
10.1 Southeast Asia Irritable Bowel Syndrome (IBS) Sales by Company
10.1.1 Southeast Asia Irritable Bowel Syndrome (IBS) Sales by Company (2016-2021)
10.1.2 Southeast Asia Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021)
10.2 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Breakdown by Type
10.2.1 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Irritable Bowel Syndrome (IBS) Sales Breakdown by Application
10.3.1 Southeast Asia Million Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia Million Units Sales Breakdown by Application (2022-2027)

11 India Irritable Bowel Syndrome (IBS) Market Facts & Figures
11.1 India Irritable Bowel Syndrome (IBS) Sales by Company
11.1.1 India Irritable Bowel Syndrome (IBS) Sales by Company (2016-2021)
11.1.2 India Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021)
11.2 India Irritable Bowel Syndrome (IBS) Sales Breakdown by Type
11.2.1 India Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2016-2021)
11.2.2 India Irritable Bowel Syndrome (IBS) Sales Breakdown by Type (2022-2027)
11.3 India Irritable Bowel Syndrome (IBS) Sales Breakdown by Application
11.3.1 India Irritable Bowel Syndrome (IBS) Sales Breakdown by Application (2016-2021)
11.3.2 India Irritable Bowel Syndrome (IBS) Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Irritable Bowel Syndrome (IBS) Business
12.1 Bausch Health
12.1.1 Bausch Health Corporation Information
12.1.2 Bausch Health Business Overview
12.1.3 Bausch Health Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bausch Health Irritable Bowel Syndrome (IBS) Products Offered
12.1.5 Bausch Health Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Business Overview
12.2.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Allergan Irritable Bowel Syndrome (IBS) Products Offered
12.2.5 Allergan Recent Development
12.3 Takeda
12.3.1 Takeda Corporation Information
12.3.2 Takeda Business Overview
12.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Takeda Irritable Bowel Syndrome (IBS) Products Offered
12.3.5 Takeda Recent Development
12.4 Sucampo Pharmaceuticals (Mallinckrodt)
12.4.1 Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information
12.4.2 Sucampo Pharmaceuticals (Mallinckrodt) Business Overview
12.4.3 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Products Offered
12.4.5 Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
12.5 Sebela Pharmaceuticals Inc
12.5.1 Sebela Pharmaceuticals Inc Corporation Information
12.5.2 Sebela Pharmaceuticals Inc Business Overview
12.5.3 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Products Offered
12.5.5 Sebela Pharmaceuticals Inc Recent Development
12.6 Astellas Pharmaceuticals
12.6.1 Astellas Pharmaceuticals Corporation Information
12.6.2 Astellas Pharmaceuticals Business Overview
12.6.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Products Offered
12.6.5 Astellas Pharmaceuticals Recent Development
…

13 Irritable Bowel Syndrome (IBS) Manufacturing Cost Analysis
13.1 Irritable Bowel Syndrome (IBS) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)
13.4 Irritable Bowel Syndrome (IBS) Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Irritable Bowel Syndrome (IBS) Distributors List
14.3 Irritable Bowel Syndrome (IBS) Customers

15 Market Dynamics
15.1 Irritable Bowel Syndrome (IBS) Market Trends
15.2 Irritable Bowel Syndrome (IBS) Drivers
15.3 Irritable Bowel Syndrome (IBS) Market Challenges
15.4 Irritable Bowel Syndrome (IBS) Market Restraints

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Irritable Bowel Syndrome (IBS) Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Irritable Bowel Syndrome (IBS) Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Irritable Bowel Syndrome (IBS) Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Region (2016-2021)
Table 5. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Region (2016-2021)
Table 6. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Irritable Bowel Syndrome (IBS) Revenue Share by Region (2016-2021)
Table 8. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) Forecast by Region (2022-2027)
Table 9. Global Irritable Bowel Syndrome (IBS) Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Irritable Bowel Syndrome (IBS) Revenue Share Forecast by Region (2022-2027)
Table 12. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) of Key Companies (2016-2021)
Table 13. Global Irritable Bowel Syndrome (IBS) Sales Share by Company (2016-2021)
Table 14. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Irritable Bowel Syndrome (IBS) Revenue Share by Company (2016-2021)
Table 16. Global Irritable Bowel Syndrome (IBS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Irritable Bowel Syndrome (IBS) as of 2020)
Table 17. Global Irritable Bowel Syndrome (IBS) Average Price (USD/K Units) of Key Company (2016-2021)
Table 18. Manufacturers Irritable Bowel Syndrome (IBS) Manufacturing Sites and Area Served
Table 19. Manufacturers Irritable Bowel Syndrome (IBS) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Type (2016-2021)
Table 22. Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2016-2021)
Table 23. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Irritable Bowel Syndrome (IBS) Price (USD/K Units) by Type (2016-2021)
Table 25. Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2022-2027)
Table 26. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2022-2027)
Table 28. Global Irritable Bowel Syndrome (IBS) Price (USD/K Units) by Type (2022-2027)
Table 29. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2016-2021)
Table 30. Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2016-2021)
Table 31. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Irritable Bowel Syndrome (IBS) Price (USD/K Units) by Application (2016-2021)
Table 33. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) by Application (2022-2027)
Table 34. Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2022-2027)
Table 35. Global Irritable Bowel Syndrome (IBS) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2022-2027)
Table 37. Global Irritable Bowel Syndrome (IBS) Price (USD/K Units) by Application (2022-2027)
Table 38. North America Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2016-2021)
Table 39. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2021)
Table 40. North America Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2016-2021)
Table 42. North America Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 43. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 44. North America Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 45. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2022-2027)
Table 46. North America Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 47. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 48. North America Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 49. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2022-2027)
Table 50. Europe Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2016-2021)
Table 51. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2021)
Table 52. Europe Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2016-2021)
Table 54. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 55. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 56. Europe Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 57. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2022-2027)
Table 58. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 59. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 60. Europe Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 61. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2022-2027)
Table 62. China Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2016-2021)
Table 63. China Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2021)
Table 64. China Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2016-2021)
Table 66. China Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 67. China Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 68. China Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 69. China Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2022-2027)
Table 70. China Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 71. China Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 72. China Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 73. China Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2022-2027)
Table 74. Japan Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2016-2021)
Table 75. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2021)
Table 76. Japan Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2016-2021)
Table 78. Japan Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 79. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 80. Japan Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 81. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2022-2027)
Table 82. Japan Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 83. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 84. Japan Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 85. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2016-2021)
Table 87. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 91. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 93. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 95. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 97. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2022-2027)
Table 98. India Irritable Bowel Syndrome (IBS) Sales (Million Units) by Company (2016-2021)
Table 99. India Irritable Bowel Syndrome (IBS) Sales Market Share by Company (2016-2021)
Table 100. India Irritable Bowel Syndrome (IBS) Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Irritable Bowel Syndrome (IBS) Revenue Market Share by Company (2016-2021)
Table 102. India Irritable Bowel Syndrome (IBS) Sales by Type (2016-2021) & (Million Units)
Table 103. India Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2016-2021)
Table 104. India Irritable Bowel Syndrome (IBS) Sales by Type (2022-2027) & (Million Units)
Table 105. India Irritable Bowel Syndrome (IBS) Sales Market Share by Type (2022-2027)
Table 106. India Irritable Bowel Syndrome (IBS) Sales by Application (2016-2021) & (Million Units)
Table 107. India Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2016-2021)
Table 108. India Irritable Bowel Syndrome (IBS) Sales by Application (2022-2027) & (Million Units)
Table 109. India Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2022-2027)
Table 110. Bausch Health Corporation Information
Table 111. Bausch Health Description and Business Overview
Table 112. Bausch Health Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 113. Bausch Health Irritable Bowel Syndrome (IBS) Product
Table 114. Bausch Health Recent Development
Table 115. Allergan Corporation Information
Table 116. Allergan Description and Business Overview
Table 117. Allergan Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 118. Allergan Irritable Bowel Syndrome (IBS) Product
Table 119. Allergan Recent Development
Table 120. Takeda Corporation Information
Table 121. Takeda Description and Business Overview
Table 122. Takeda Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 123. Takeda Irritable Bowel Syndrome (IBS) Product
Table 124. Takeda Recent Development
Table 125. Sucampo Pharmaceuticals (Mallinckrodt) Corporation Information
Table 126. Sucampo Pharmaceuticals (Mallinckrodt) Description and Business Overview
Table 127. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 128. Sucampo Pharmaceuticals (Mallinckrodt) Irritable Bowel Syndrome (IBS) Product
Table 129. Sucampo Pharmaceuticals (Mallinckrodt) Recent Development
Table 130. Sebela Pharmaceuticals Inc Corporation Information
Table 131. Sebela Pharmaceuticals Inc Description and Business Overview
Table 132. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 133. Sebela Pharmaceuticals Inc Irritable Bowel Syndrome (IBS) Product
Table 134. Sebela Pharmaceuticals Inc Recent Development
Table 135. Astellas Pharmaceuticals Corporation Information
Table 136. Astellas Pharmaceuticals Description and Business Overview
Table 137. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales (Million Units), Revenue (Million USD), Price (USD/K Units) and Gross Margin (2016-2021)
Table 138. Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table 139. Astellas Pharmaceuticals Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Irritable Bowel Syndrome (IBS) Distributors List
Table 143. Irritable Bowel Syndrome (IBS) Customers List
Table 144. Irritable Bowel Syndrome (IBS) Market Trends
Table 145. Irritable Bowel Syndrome (IBS) Market Drivers
Table 146. Irritable Bowel Syndrome (IBS) Market Challenges
Table 147. Irritable Bowel Syndrome (IBS) Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Irritable Bowel Syndrome (IBS) Product Picture
Figure 2. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2021 & 2027
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2021 & 2027
Figure 6. Women Examples
Figure 7. Men Examples
Figure 8. Global Irritable Bowel Syndrome (IBS) Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Irritable Bowel Syndrome (IBS) Sales Growth Rate (2016-2027) & (US$ Million)
Figure 10. Global Irritable Bowel Syndrome (IBS) Sales (Million Units) Growth Rate (2016-2027)
Figure 11. Global Irritable Bowel Syndrome (IBS) Price Trends Growth Rate (2016-2027) (USD/K Units)
Figure 12. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region: 2016 VS 2021
Figure 13. Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Region: 2021 VS 2027
Figure 14. North America Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 15. North America Irritable Bowel Syndrome (IBS) Sales (Million Units) Growth Rate (2016-2027)
Figure 16. Europe Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. Europe Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2016-2027)
Figure 18. China Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. China Irritable Bowel Syndrome (IBS) Sales (Million USD) and Growth Rate (2016-2027)
Figure 20. Japan Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. Japan Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2016-2027)
Figure 22. Southeast Asia Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Southeast Asia Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2016-2027)
Figure 24. India Irritable Bowel Syndrome (IBS) Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. India Irritable Bowel Syndrome (IBS) Sales (Million USD) Growth Rate (2016-2027)
Figure 26. Global 5 Largest Irritable Bowel Syndrome (IBS) Players Market Share by Revenue in Irritable Bowel Syndrome (IBS): 2016 & 2020
Figure 27. Irritable Bowel Syndrome (IBS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 28. Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2016-2021)
Figure 29. Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate by Type in 2016 & 2020
Figure 30. Global Irritable Bowel Syndrome (IBS) Revenue Share by Application (2016-2021)
Figure 31. Global Irritable Bowel Syndrome (IBS) Revenue Growth Rate by Application in 2016 & 2020
Figure 32. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 33. North America Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 34. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 35. Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 36. China Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 37. China Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 38. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 39. Japan Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 40. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 41. Southeast Asia Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 42. India Irritable Bowel Syndrome (IBS) Sales Market Share by Type in 2020
Figure 43. India Irritable Bowel Syndrome (IBS) Sales Market Share by Application in 2020
Figure 44. Key Raw Materials Price Trend
Figure 45. Manufacturing Cost Structure of Irritable Bowel Syndrome (IBS)
Figure 46. Manufacturing Process Analysis of Irritable Bowel Syndrome (IBS)
Figure 47. Irritable Bowel Syndrome (IBS) Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Global Rx Irritable Bowel Syndrome (IBS) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-6000 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、過敏性腸症候群（IBS）処方薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（IBS-D薬、IBS-C薬、その他）、用途別市場規模（女性用、男性用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、...

便秘薬による過敏性腸症候群のグローバル市場調査 2019年

Global Irritable Bowel Syndrome with Constipation Drugs Market Professional Survey Report 2019
QYR9NV07074 2019年11月12日 103Pages
※本調査レポートは、便秘薬による過敏性腸症候群の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他...

下痢を伴う過敏性腸症候群（IBS-D）薬のグローバル市場調査 2019年

Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Professional Survey Report 2019
QYR9NV07075 2019年11月12日 108Pages
※本調査レポートは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、序文、エルキサドリン、アロセトロン、リファキシミン...

世界のウェスト症候群市場規模・現状・予測（2021年-2027年）

Global West Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-5039 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ウェスト症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（治療法、新薬）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年）

Global Inflammatory Bowel Disease Therapy Market Size, Status and Forecast 2021-2027
QFJ1-4364 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、炎症性腸疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（潰瘍性大腸炎、クローン病、その他）、用途別市場規模（病院、医学研究機構、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

世界のレット症候群市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Market Size, Status and Forecast 2021-2027
QFJ1-4831 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、レット症候群の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市...

世界の肝腎症候群治療市場規模・現状・予測（2021年-2027年）

Global Hepatorenal Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4305 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、肝腎症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ヘパトレン、テルリバズ、グリプレシン、ルカシン、その他）、用途別市場規模（1型肝腎症候群、2型肝腎症候群）、主要地域別市場規模（北米、アメ...

世界のレット症候群治療市場規模・現状・予測（2021年-2027年）

Global Rett Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5994 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、レット症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗てんかん薬、抗てんかん薬、鎮静催眠薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のレノックス・ガストー症候群治療市場規模・現状・予測（2021年-2027年）

Global Lennox-Gastaut Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4422 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、レノックス・ガストー症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（非外科的治療、外科的治療）、用途別市場規模（発作、眼球異常、脳波所見、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のQT延長症候群治療市場規模・現状・予測（2021年-2027年）

Global Long QT Syndrome Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4438 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、QT延長症候群治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（医療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の過敏性腸症候群（IBS）処方薬市場規模・現状・予測（2021年-2027年） Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. Market Analysis and Insights: Global Rx Irritable Bowel Syndrome (IBS) Drugs Market The global Rx Irritable Bowel Syndrome (IBS…
下痢を伴う過敏性腸症候群（IBS-D）薬のグローバル市場調査 2019年 The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level,…
便秘薬による過敏性腸症候群のグローバル市場調査 2019年 The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Constipation Drugs volume and value at global level, regiona…
世界の炎症性腸疾患治療市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
世界の炎症性腸疾患体外診断市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indicatio…